V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270014961 | 270010783 | null | 95 | Curative (C) | 2014-02-07 | 2014-03-26 | OXALIPLATIN | N | N | 270005860 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270014962 | 270010783 | 1.92 | 50.95 | Disease modification (D) | 2014-02-01 | 2014-06-23 | Chlorambucil | 01 | N | 270005860 | IBRUTINIB |
| 270014963 | 270010784 | 1.6 | 76.4 | null | 2018-07-08 | 2018-07-24 | OXALIPLATIN | N | N | 270005991 | PEMBROLIZUMAB |
| 270014964 | 270010785 | 1.92 | 56.6 | Disease modification (D) | 2018-03-25 | 2018-03-27 | IRINOTECAN + MDG + PANITUMUMAB | N | N | 270005991 | CAP + RT |
| 270014965 | 270015031 | 1.67 | 80 | Curative (C) | 2018-01-11 | 2018-01-14 | Capecitabine (14 days)+Carboplatin | N | N | 270006274 | PACLITAXEL |
| 270014966 | 270010790 | 1.8 | 86.8 | Curative (C) | 2015-12-09 | 2015-12-14 | Abiraterone | N | N | 270006324 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270014967 | 270010791 | 1.58 | 91.6 | Curative (C) | 2016-10-15 | 2016-10-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 270006324 | FLUOROURACIL + MITOMYCIN + RT |
| 270014968 | 270010791 | null | null | null | 2017-01-22 | 2017-03-10 | IRINOTECAN + MDG + PANITUMUMAB | null | null | 270006324 | IRINOTECAN + PANITUMUMAB + MDG |
| 270014969 | 270010792 | 1.78 | 74.6 | Palliative (P) | 2016-03-15 | 2016-03-15 | DA 3 + 10 | N | N | 270006621 | BEVACIZUMAB + CAPE + IRINOTECAN |
| 270014970 | 270010794 | 1.6 | 61.9 | Disease modification (D) | 2016-08-10 | 2016-08-19 | Bevacizumab + Cape + Oxali 14day | 02 | N | 270006622 | BEVACIZUMAB + CAPECITABINE |
| 270014971 | 270010795 | 1.78 | 71.1 | Curative (C) | 2014-08-23 | 2014-09-15 | BREVITY TRIAL | null | Y | 270006717 | RUXOLITINIB |
| 270014972 | 270010795 | null | null | Curative (C) | 2017-09-21 | 2017-11-02 | Bortezomib + CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB | null | Y | 270006717 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270014973 | 270010795 | 1.76 | null | Curative (C) | 2017-05-13 | 2017-06-03 | CARBOPLATIN + RT | 02 | null | 270006717 | MPV |
| 270014974 | 270010796 | 1.8 | 40.3 | null | 2017-02-19 | 2017-03-03 | CARBOPLATIN + RT | 02 | N | 270007266 | CAP + RT |
| 270014975 | 270010796 | 1.83 | null | Palliative (P) | null | 2014-03-28 | CYTARABINE | null | null | 270007266 | CARBOPLATIN + RT |
| 270014976 | 270010796 | 1.63 | 61 | Palliative (P) | 2016-12-29 | 2016-12-29 | Chlorambucil | 2 | N | 270007266 | FOXTROT TRIAL |
| 270014977 | 270010798 | 1.69 | 60 | Disease modification (D) | 2019-02-12 | 2019-02-14 | Carboplatin + Cetux + FU (Cycle 1) | 02 | N | 270008125 | PEMETREXED |
| 270014978 | 270015036 | 1.55 | null | Curative (C) | 2018-08-01 | 2018-08-02 | CARBOPLATIN + RT | N | N | 270008125 | BEVACIZUMAB + IRINOTECAN + MdG |
| 270014979 | 270015036 | null | 83 | Curative (C) | 2014-09-07 | 2014-09-14 | Capecitabine + Mitomycin | 02 | N | 270008125 | BEVACIZUMAB + CAPECITABINE |
| 270014980 | 270015036 | 1.73 | 61.9 | Palliative (P) | 2017-06-26 | 2017-07-02 | CARBOPLATIN + RT | 02 | N | 270008125 | CARBOPLATIN + CETUXIMAB + FU |
| 270014981 | 270010800 | 1.55 | 82 | Palliative (P) | 2018-09-28 | 2018-09-29 | CETUXIMAB + OXALIPLATIN | 2 | N | 270008848 | BEVACIZUMAB + CAPE + IRINOTECAN |
| 270014982 | 270010801 | 1.94 | 63.35 | Curative (C) | 2017-02-27 | 2017-02-27 | R GCVP | 02 | Y | 270009055 | ARSENIC TRIOXIDE |
| 270014983 | 270010803 | 1.7 | 70.1 | Palliative (P) | 2017-01-05 | 2017-01-10 | CAPECITABINE + CARBOPLATIN + Cetuximab | Y | N | 270009174 | CARBOPLATIN + CETUXIMAB + FU |
| 270014984 | 270010805 | 1.82 | 62 | Curative (C) | null | 2017-10-17 | Irinotecan + Raltitrexed | 02 | N | 270009308 | CARBO + FLUOROURACIL |
| 270014985 | 270015037 | 1.73 | 76 | null | 2016-11-15 | 2016-11-15 | CETUXIMAB + MDG | 02 | N | 270010216 | CAPECITABINE + CARBOPLATIN |
| 270014986 | 270010806 | 1.7 | 76.9 | Adjuvant (A) | 2016-02-16 | 2016-02-27 | CARBOPLATIN + RT | N | N | 270010445 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270014987 | 270010809 | 1.65 | 57 | Curative (C) | 2017-12-12 | 2018-01-10 | CAPECITABINE + CETUXIMAB | N | N | 270010649 | IBRUTINIB |
| 270014988 | 270010813 | 1.74 | 101 | Palliative (P) | 2015-02-02 | 2016-01-26 | Abiraterone | N | null | 270010649 | PEMBROLIZUMAB |
| 270014989 | 270010814 | 1.82 | 76.4 | null | 2016-09-21 | 2016-10-08 | Docetaxel 75mg/m2 (21 day) | Y | N | 270010721 | CARBOPLATIN + IRINOTECAN |
| 270014990 | 270017302 | 1.6 | 83 | Palliative (P) | 2016-04-09 | 2016-06-29 | Carbo F | 02 | N | 270011630 | DOCETAXEL |
| 270014991 | 270017302 | 1.66 | 78.8 | null | null | 2018-01-14 | GemCarbo Days 1+8 | null | N | 270011630 | CARBO + FLUOROURACIL |
| 270014992 | 270010815 | 1.6 | null | Palliative (P) | 2018-03-25 | 2018-07-22 | Pazopanib | N | null | 270012127 | DOXORUBICIN |
| 270014993 | 270010816 | 1.76 | 68 | Curative (C) | 2017-03-24 | 2017-03-29 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | 270012127 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270014994 | 270010821 | 1.79 | 54.6 | Disease modification (D) | 2017-11-19 | 2017-11-20 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + MESNA + RITUXIMAB | 2 | N | 270013426 | CVP R |
| 270014995 | 270019316 | 1.7 | 90.4 | Curative (C) | 2019-02-10 | 2019-02-13 | Bevacizumab + Cape + Oxali 21day | 02 | N | 270013472 | CETUXIMAB + IRINOTECAN |
| 270014996 | 270019316 | 1.62 | null | Curative (C) | 2016-11-17 | 2016-11-17 | RUXOLITINIB | 2 | N | 270013472 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270014997 | 270019316 | 1.7 | 80 | Palliative (P) | 2017-12-19 | 2017-12-21 | CARBOPLATIN + RT | 99 | N | 270013472 | CYTARABINE |
| 270014998 | 270010822 | 1.84 | 98.1 | Curative (C) | 2017-09-26 | 2017-10-28 | Docetaxel 75mg/m2 (21 day) | N | N | 270014503 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 270014999 | 270010824 | 1.68 | 59.6 | Curative (C) | 2014-07-12 | 2014-07-15 | Bevacizumab + Capecitabine | 02 | N | 270014507 | CISPLATIN + PEMETREXED |
| 270015000 | 270010825 | 1.72 | 112.3 | Palliative (P) | 2019-01-24 | 2019-01-24 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 270014507 | CARBOPLATIN + PACLITAXEL |
| 270015001 | 270010825 | 1.91 | 80 | Disease modification (D) | 2018-01-26 | 2018-02-16 | Carbo F | N | N | 270014507 | CAPECITABINE + CETUXIMAB + IRINOTECAN |
| 270015002 | 270010827 | 1.78 | 0 | Disease modification (D) | 2018-10-06 | 2018-10-07 | Carboplatin + Cetux + FU (>Cycle 2) | 02 | N | 270014838 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 270015003 | 270015048 | 1.62 | null | Curative (C) | 2017-08-03 | 2017-08-10 | Bevacizumab + FLUOROURACIL + IRINOTECAN | N | N | 270015179 | PAZOPANIB |
| 270015004 | 270015048 | 1.75 | 78.6 | Curative (C) | 2016-10-04 | 2016-10-14 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 270015179 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270015005 | 270010829 | 1.67 | 58.8 | Palliative (P) | 2017-07-28 | 2017-08-25 | Cabazitaxel | N | N | 270015249 | GEMCARBO |
| 270015006 | 270010830 | 1.79 | null | Palliative (P) | 2017-12-27 | 2018-02-08 | AXITINIB | null | null | 270015709 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270015007 | 270010832 | 1.76 | 128 | Palliative (P) | 2014-09-23 | 2014-09-26 | Docetaxel 75mg/m2 (21 day) | 02 | N | 270015756 | CARBOPLATIN + ETOPOSIDE |
| 270015008 | 270010833 | null | 78 | Curative (C) | 2018-02-12 | 2018-02-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 270015771 | SCOT TRIAL |
| 270015009 | 270010834 | 1.68 | 80 | Curative (C) | 2017-05-09 | 2017-05-09 | CETUXIMAB + MDG | N | N | 270016014 | FOXTROT TRIAL |
| 270015010 | 270010837 | 1.72 | 92.2 | Curative (C) | 2017-10-13 | 2017-10-27 | CARBOPLATIN + PACLITAXEL | 2 | N | 270016059 | CAPECITABINE + CETUXIMAB + IRINOTECAN |